These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34987908)

  • 21. Persistent Pulmonary Hypertension of the Newborn: Pathophysiological Mechanisms and Novel Therapeutic Approaches.
    Martinho S; Adão R; Leite-Moreira AF; Brás-Silva C
    Front Pediatr; 2020; 8():342. PubMed ID: 32850518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
    Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
    Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension.
    Steinhorn RH; Kinsella JP; Pierce C; Butrous G; Dilleen M; Oakes M; Wessel DL
    J Pediatr; 2009 Dec; 155(6):841-847.e1. PubMed ID: 19836028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sildenafil for pulmonary hypertension in neonates.
    Shah PS; Ohlsson A
    Cochrane Database Syst Rev; 2011 Aug; (8):CD005494. PubMed ID: 21833954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors and mortality among newborns with persistent pulmonary hypertension.
    Razzaq A; Iqbal Quddusi A; Nizami N
    Pak J Med Sci; 2013 Sep; 29(5):1099-104. PubMed ID: 24353699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antenatal use of bosentan and/or sildenafil attenuates pulmonary features in rats with congenital diaphragmatic hernia.
    Lemus-Varela Mde L; Soliz A; Gómez-Meda BC; Zamora-Perez AL; Ornelas-Aguirre JM; Melnikov V; Torres-Mendoza BM; Zúñiga-González GM
    World J Pediatr; 2014 Nov; 10(4):354-9. PubMed ID: 25515807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn.
    Reynolds EW; Ellington JG; Vranicar M; Bada HS
    Pediatrics; 2004 Nov; 114(5):1297-304. PubMed ID: 15520111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ruptured chordae tendineae of tricuspid valve in neonate with intractable persistent pulmonary hypertension: a case report and literature review].
    Jiao JC; Li L; Tao SG; He XJ; Meng LZ; Sun M; Qiu XL; Ma L
    Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):294-298. PubMed ID: 33775048
    [No Abstract]   [Full Text] [Related]  

  • 29. Sildenafil for pulmonary hypertension in neonates: An updated systematic review and meta-analysis.
    He Z; Zhu S; Zhou K; Jin Y; He L; Xu W; Lao C; Liu G; Han S
    Pediatr Pulmonol; 2021 Aug; 56(8):2399-2412. PubMed ID: 33983650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats.
    Itoh T; Nagaya N; Fujii T; Iwase T; Nakanishi N; Hamada K; Kangawa K; Kimura H
    Am J Respir Crit Care Med; 2004 Jan; 169(1):34-8. PubMed ID: 14525801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retrospective analysis of elective caesarean section and respiratory distress syndrome in the term neonates].
    Wu XJ; Zhang XD; Shi LP
    Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):658-61. PubMed ID: 20021786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial.
    Steinhorn RH; Fineman J; Kusic-Pajic A; Cornelisse P; Gehin M; Nowbakht P; Pierce CM; Beghetti M;
    J Pediatr; 2016 Oct; 177():90-96.e3. PubMed ID: 27502103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy with oral sildenafil and beraprost for pulmonary arterial hypertension associated with CREST syndrome.
    Miwa K; Matsubara T; Uno Y; Yasuda T; Sakata K; Tsuda T; Kanaya H
    Int Heart J; 2007 May; 48(3):417-22. PubMed ID: 17592207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent pulmonary hypertension in the newborn: therapeutic effect of sildenafil.
    Cruz-Blanquel A; Espinosa-Oropeza A; Romo-Hernández G; Carrillo-Alarcón L; Ponce-Monter H; Ortiz MI
    Proc West Pharmacol Soc; 2008; 51():73-7. PubMed ID: 19544683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study.
    Baquero H; Soliz A; Neira F; Venegas ME; Sola A
    Pediatrics; 2006 Apr; 117(4):1077-83. PubMed ID: 16585301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Efficacy and Safety of Different Doses of Sildenafil in the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Network Meta-analysis.
    Sun L; Wang C; Zhou Y; Sun W; Wang C
    Front Pharmacol; 2021; 12():697287. PubMed ID: 34630080
    [No Abstract]   [Full Text] [Related]  

  • 37. Bosentan in the treatment of persistent pulmonary hypertension in newborns: a systematic review and meta-analysis.
    Gao N; Lv Y; Cui Y; Wang P; He X
    Cardiol Young; 2024 Feb; ():1-8. PubMed ID: 38329072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].
    Raposo-Sonnenfeld I; Otero-González I; Blanco-Aparicio M; Ferrer-Barba A; Medrano-López C
    Rev Esp Cardiol; 2007 Apr; 60(4):366-72. PubMed ID: 17521545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report.
    Daniyan O; Ezeanosike O; Obu D; Ujunwa F
    J Cardiovasc Thorac Res; 2022; 14(2):141-143. PubMed ID: 35935381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effect of sildenafil is maintained in pulmonary arterial hypertension patients chronically treated with bosentan.
    Hatano M; Yao A; Kinugawa K; Hirata Y; Nagai R
    Int Heart J; 2011; 52(4):233-9. PubMed ID: 21828950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.